Blog
Gynecological cancers, including ovarian, cervical, uterine, and endometrial cancers, remain some of the most complex malignancies to study. While survival has improved in many cancers, uterine corpus cancer is trending...
Gynecological cancers, including ovarian, cervical, uterine, and endometrial cancers, remain some of the most complex malignancies to study. While survival has improved in many cancers, uterine corpus cancer is trending...
The spatial transcriptomics field provides unrivaled insights into gene expression within intact tissue architecture which is crucial for both exploratory discovery and targeted hypothesis testing. Two paradigms stand out: the...
Signios Biosciences details how advanced single-cell and spatial transcriptomics support neuroscience research into Alzheimer's, FTD, TBI, and Friedreich's Ataxia, aiding new therapy development....
Signios Biosciences details how advanced single-cell and spatial transcriptomics support neuroscience research into Alzheimer's, FTD, TBI, and Friedreich's Ataxia, aiding new therapy development....
Today, we launch Signios Bio, a rebrand of what was previously known as MedGenome US Research Services. With a focus on scientific collaboration and breakthrough discovery, Signios Bio offers an...
Traumatic brain injury (TBI) poses complex challenges for researchers aiming to understand cellular responses post-injury. Professor Michelle H. Theus of Virginia Tech partnered with MedGenome to shed light on the...
The immune system is a complex network of cells and molecules that defend the body against foreign invaders. Central to this defense mechanism are the T and B cells, which...
The Human Cell Atlas (HCA) consortium has unveiled a landmark collection of over 40 studies from more than 100 countries, marking a significant leap in our understanding of the human...
Lung cancer remains the leading cause of cancer-related deaths globally, accounting for 18.4% of all cancer fatalities. Smoking is the primary cause of lung cancer, responsible for 80-90% of lung...